December 29th 2023
Our top coverage from the CHEST Annual Meeting 2023 explored various topics, including strategies to prevent air pollutant exposure and keys to achieving equity in lung cancer screenings.
Evolving Treatment Strategies in the Management of Pulmonary Arterial Hypertension: Key Insights for the Pharmacist, featuring a Patient Perspective
1.5 Credits / Pulmonology/Respiratory
View More
Advances in EGFR Exon 20 Insertion-Positive Non–Small Cell Lung Cancer: A Focus on Specialty Pharmacy Interventions
1.5 Credits / Oncology, Pulmonology/Respiratory
View More
Advances and Best Practices for Managed Care Pharmacists and the Treatment of Patients with Alpha-1 Antitrypsin Deficiency
1.0 Credit / Pulmonology/Respiratory
View More
Bronchial Hyperresponsiveness May Predict Cough-Variant Asthma in Adults With Chronic Cough
November 19th 2021The study found that cough severity and cough-related quality of life were not related to the severity of bronchial hyperresponsiveness in nonsmoking adults with cough-variant asthma.
Read More
Dr Ron Eccles on Measuring the Blinding That Happens in Chronic Cough Therapy Trials
November 9th 2021Most adverse events in trials of adenosine triphosphate (ATP) blockers for chronic cough are related to taste, which may inadvertently cause the studies to become unblinded to patients, and a way of measuring this to know the extent of the problem is needed, said Ron Eccles, BSc, PhD, DSc, emeritus professor at Cardiff University.
Watch
Medicare Advantage–Pharmacy Partnership Improves Influenza and Pneumococcal Vaccination Rates
Patients whose pharmacy receives notification of their immunization gap have twice the odds of receiving immunizations compared with those whose pharmacy does not receive the notification.
Read More
Dr Peter Dicpinigaitis Discusses the State of Chronic Cough Treatment
October 5th 2021Peter Dicpinigaitis, MD, professor of medicine at the Albert Einstein College of Medicine, director of the Montefiore Cough Center, and editor-in-chief of LUNG, addresses the lack of approved treatments for chronic cough in the United States, current off-label remedies, and the prospect of future approvals.
Watch
Dr Ron Eccles on Therapies That Block ATP and Reduce Cough
September 29th 2021Therapies that block adenosine triphosphate (ATP) can reduce the irritation that causes cough, and some currently being studied also don’t have taste side effects that can confound clinical trial results, explained Ron Eccles, BSc, PhD, DSc, emeritus profess at Cardiff University.
Watch
Back-to-School Virus Watch: Children Are at Risk for More Than Just COVID-19
September 7th 2021Researchers have found that the COVID-19 pandemic has caused potentially millions of children to miss routine vaccines. During a time of back-to-school excitement and reversals of transmission prevention efforts in some states, children may be at risk of facing a slew of non-COVID-19 viral outbreaks.
Read More
Study Adds Knowledge to Asthma Severity’s Effects on Health-Related Quality of Life
September 4th 2021The authors said the results may prove useful in adding to the relatively small body of information known about the relationship between health-related quality of life and how the severity of asthma affects a patient’s preference values.
Read More
Hospital Discharge Diagnosis Position: Impact on Adult Pneumonia Burden Estimates
Disease burden estimates of pneumonia-associated hospitalizations are more sensitive when including pneumonia coded in any diagnosis field vs in only the first discharge diagnosis field.
Read More
Mortality Risk Stratification Helps Identify Patients With COVID-19 at Risk of Adverse Outcomes
August 13th 2021Mortality risk stratification can identify patients with COVID-19 who are at higher risk of mortality, discharge to skilled nursing facility, and readmission, and may benefit from focused intervention strategies.
Read More
Internal CDC Report Underscores Delta Dangers, COVID-19 Communication Woes
July 30th 2021A newly released internal CDC report shows the agency's communication struggles and its challenges in combatting the virulent delta variant, acknowledges the need for universal masking, and illustrates the effectiveness of vaccines in preventing more severe illness and death in those who are inoculated.
Read More
Dr Ron Eccles Outlines the Challenges of the Placebo Effect for Cough Medicines
July 24th 2021Patients may find a placebo effect beneficial, but it causes issues in a clinical trial and makes it difficult to understand the efficacy of a pharmacological agent, said Ron Eccles, BSc, PhD, DSc, emeritus professor at Cardiff University.
Watch